New Entity- Prostaglandin-Associated Periorbitopathy

July 7, 2011

Glaucoma Today: A new syndrome has been identified, and just like Flomax-related floppy-iris syndrome, it’s something I have notice myself in hindsight. Patients taking prostaglandins (Xalatan, Travatan, Lumigan) can sometimes develop deepening of the upper eye lid sulcus, ptosis, periorbital fat atrophy and retraction of the lower lids. They look a  little like those with scleroderma. Let’s keep an eye out for this side effect, as it is cosmetically significant.

 

 

You might also enjoy...

Comments

Jump down to form below to submit your own comments

2 Responses to “New Entity- Prostaglandin-Associated Periorbitopathy”

  1. David Richardson, MD on July 7th, 2011 12:18 pm

    Dr. Weitzner,
    Would it be possible to set up future posts with links to the source articles? Although Google is often acceptable, there are times when it has not yet indexed the latest journal abstracts.
    Thanks,
    David Richardson, MD

  2. ari on July 7th, 2011 6:53 pm

    i read it in print- page 51 in volume 9, no. 3

Trackback URL
http://eyedocnews.com/005633-new-entity-prosraglandin-associated-periorbitopathy/trackback/

Have insights to contribute? Please submit your comment below